2004 discharge: European Agency for the Evaluation of Medicinal Products

Having examined the Agency’s revenue and expenditure account and the observations made by the Court of Auditors, the Council recommends the European Parliament to give a discharge to the Director of the Agency in respect of the implementation of the budget for the financial year 2004.

In doing so, the Council confirms that EUR 15 million (93 %) of the EUR 16.1 million in appropriations carried forward from the financial year 2003 to the financial year 2004 have been used. In addition, EUR 22,7 million in appropriations have been carried forward from the financial year

2004 to the financial year 2005 and EUR 3.4 million have been cancelled.

In parallel, the Council makes accompanying comments on the discharge which should be followed up. In particular, it:

§         shares the Court's observation on the Audit Advisory Committee and calls on the Agency, on account of its permanent nature, to provide for its existence and operating procedures in the rules which govern the Agency's internal organisation;

§         shares the Court’s opinion on the need to start a new invitation to tender on services provided by banks.